NA
XYL icon

Navellier & Associates’s Xylem XYL Stock Holding History

Navellier & Associates’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,678
Closed -$201K – 392
2026
Q1 		$201K Hold
1,678
– – 0.02% 320
2025
Q4 		$229K Buy
1,678
+5
+0.3% +$719 0.03% 307
2025
Q3 		$247K Buy
1,673
+4
+0.2% +$555 0.03% 332
2025
Q2 		$216K Buy
1,669
+5
+0.3% +$606 0.03% 294
2025
Q1 		$204K Buy
+1,664
New +$206K 0.03% 293
2024
Q4 		– Sell
-1,653
Closed -$223K – 367
2024
Q3 		$223K Buy
1,653
+4
+0.2% +$535 0.03% 302
2024
Q2 		$224K Buy
1,649
+5
+0.3% +$680 0.03% 313
2024
Q1 		$213K Buy
+1,644
New +$199K 0.03% 321
2022
Q1 		– Sell
-59,108
Closed -$7.09M – 361
2021
Q4 		$7.09M Sell
59,108
-2,553
-4% -$317K 1.03% 23
2021
Q3 		$7.63M Buy
+61,661
New +$7.94M 1.15% 18

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Navellier & Associates's XYL Position: Q2 2026 in Review

Navellier & Associates sold out of Xylem (XYL) in Q2 2026, closing a stake of 1,678 shares — an estimated $201K sold.

Navellier & Associates first reported a position in XYL in Q3 2021 and held it in 10 quarters. The position peaked at $7.63M in Q3 2021. 1,100 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Navellier & Associates reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Navellier & Associates sold 1,678 Xylem shares in Q2 2026, an estimated $201K.
  • Navellier & Associates first reported a position in Xylem in Q3 2021 and held it in 10 quarters.
  • Navellier & Associates's Xylem position peaked at $7.63M in Q3 2021.
  • 1,100 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.